Resistance-resistant antibiotics.

作者: Eric Oldfield , Xinxin Feng

DOI: 10.1016/J.TIPS.2014.10.007

关键词:

摘要: New antibiotics are needed because drug resistance is increasing while the introduction of new decreasing. We discuss here six possible approaches to develop ‘resistance-resistant' antibiotics. First, multitarget inhibitors in which a single compound inhibits more than one target may be easier conventional combination therapies with two drugs. Second, inhibiting multiple targets same metabolic pathway expected an effective strategy owing synergy. Third, discovering multiple-target should by using sequential virtual screening. Fourth, repurposing existing drugs can lead combinations therapeutics. Fifth, need not proteins. Sixth, virulence factor formation and boosting innate immunity also decreased susceptibility resistance. Although it eliminate resistance, reviewed offer several possibilities for reducing effects mutations and, some cases, suggest that sensitivity restored otherwise drug-resistant organisms.

参考文章(73)
David Ellis, Amphotericin B: spectrum and resistance. Journal of Antimicrobial Chemotherapy. ,vol. 49, pp. 7- 10 ,(2002) , 10.1093/JAC/49.SUPPL_1.7
George Y. Liu, Anthony Essex, John T. Buchanan, Vivekanand Datta, Hal M. Hoffman, John F. Bastian, Joshua Fierer, Victor Nizet, Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity Journal of Experimental Medicine. ,vol. 202, pp. 209- 215 ,(2005) , 10.1084/JEM.20050846
Jack F. Bukowski, Hiranmoy Das, Arati Kamath, Lin Li, Lisheng Wang, Antibacterial effect of human Vγ2Vδ2 T cells in vivo Journal of Clinical Investigation. ,vol. 108, pp. 1349- 1357 ,(2001) , 10.1172/JCI13584
L. L. Silver, Challenges of Antibacterial Discovery Clinical Microbiology Reviews. ,vol. 24, pp. 71- 109 ,(2011) , 10.1128/CMR.00030-10
Gustavo Benaim, Alberto E. Paniz Mondolfi, The emerging role of amiodarone and dronedarone in Chagas disease Nature Reviews Cardiology. ,vol. 9, pp. 605- 609 ,(2012) , 10.1038/NRCARDIO.2012.108
Gustavo Benaim, John M. Sanders, Yael Garcia-Marchán, Claudia Colina, Renee Lira, Aura R. Caldera, Gilberto Payares, Cristina Sanoja, Juan Miguel Burgos, Annette Leon-Rossell, Juan Luis Concepcion, Alejandro G. Schijman, Mariano Levin, Eric Oldfield, Julio A. Urbina, Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole. Journal of Medicinal Chemistry. ,vol. 49, pp. 892- 899 ,(2006) , 10.1021/JM050691F
Kapil Tahlan, Regina Wilson, David B. Kastrinsky, Kriti Arora, Vinod Nair, Elizabeth Fischer, S. Whitney Barnes, John R. Walker, David Alland, Clifton E. Barry, Helena I. Boshoff, SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis Antimicrobial Agents and Chemotherapy. ,vol. 56, pp. 1797- 1809 ,(2012) , 10.1128/AAC.05708-11
F. Prati, E. Uliassi, M. L. Bolognesi, Two diseases, one approach: multitarget drug discovery in Alzheimer's and neglected tropical diseases MedChemComm. ,vol. 5, pp. 853- 861 ,(2014) , 10.1039/C4MD00069B
J. C. Munday, A. A. Eze, N. Baker, L. Glover, C. Clucas, D. Aguinaga Andres, M. J. Natto, I. A. Teka, J. McDonald, R. S. Lee, F. E. Graf, P. Ludin, R. J. S. Burchmore, C. M. R. Turner, A. Tait, A. MacLeod, P. Maser, M. P. Barrett, D. Horn, H. P. De Koning, Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs Journal of Antimicrobial Chemotherapy. ,vol. 69, pp. 651- 663 ,(2014) , 10.1093/JAC/DKT442